CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Back Hepatology Centers of Educational Expertise CLDFi
Dr. Kwo
Paul Y. Kwo, MD, is a Professor of Medicine (Gastroenterology & Hepatology) at The Stanford University Medical Center. After receiving his medical degree from Wayne State University School of Medicine in Detroit, Michigan, Dr. Kwo completed an internship and a residency in Baltimore at the University of Maryland. He completed his specialty training with a fellowship in gastroenterology and hepatology at the Mayo Clinic in Rochester, Minnesota.
  Ask the Expert Archive 
View All Questions Ask a Question
  CME and Independent Education  
  Physician Resources 
  My Publications More  
  Peginterferon and ribavirin for treatment of recurrent hepatitis C disease in HCV-HIV coinfected liver transplant recipients.
  Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant.
  Management of hyponatremia in clinical hepatology practice.
  Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.
  Safety and efficacy of boceprevir/peginterferon/ribavirin for HCV G1 compensated cirrhotics: Meta-analysis of 5 trials.
  Disease Educational Content  
  Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases
  Educational eNewsletter
  Hepatic Encephalopathy Update: Reports from the 2013 American College of Gastroenterology Meeting
  Educational eNewsletter
  Hepatic Encephalopathy Update: Reports From the 2013 Digestive Disease Week Annual Meeting
  Educational eNewsletter
  Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference
  Educational eNewsletter
  Hepatic Encephalopathy: A Review of Diagnostic Methods
  Educational eNewsletter
  2013 Current Insights into the Management of Hepatic Encephalopathy
  Educational Audiocast
  Hepatic Encephalopathy Update: Prophylactic Therapy to Prevent Hepatic Encephalopathy
  Educational eNewsletter
  Hepatic Encephalopathy Update: Reports from the 2012 International Liver Conference
  Educational eNewsletter
  2012 Update: Clinical Advances in the Management of Cirrhotics
  Educational Audiocast
  2012 EASL HE Posters
  Educational ePosters
  Institution Information
Stanford Medicine is committed to building partnerships within the local community to further promote community health. Through a deep understanding of common goals and a strong belief in healthy living, these community relationships help to develop and enhance public awareness through education, research, outreach and public service. By establishing and maintaining strong partnerships, Stanford Medicine can be a positive voice and advocate for community health.
Current Studies  
Institution Link  
Liver News - REUTERS
  Fibroblast growth factor analog shows promise in non-alcoholic steatohepatitis  
  Tenofovir fails to add extra hepatitis B protection for vaccinated newborns  
  Antivirals may prevent chronic HCV in recipients of infected donor kidneys  
  African-Americans less likely to respond to direct-acting antivirals for hep-C  
  View Complete News Library  
  Journal Abstracts  
  Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort  
  Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 Studies  
  Long-Term Follow-up and Quantitative Hepatitis B Surface Antigen Monitoring in North American Chronic HBV Carriers  
  Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis  
  Effects of Alcohol on the Brain in Cirrhosis: Beyond Hepatic Encephalopathy  
  Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma  
  View All Articles  
  Congress Calendar  
  March 14-18  
  APASL - Asian Pacific Association for the Study of Liver
New Delhi, Delhi, India
  March 24-25  
  GALA - GI & Liver Association of the Americas
Dallas, TX, USA
  April 11-15  
  EASL - European Association for the Study of the Liver
Paris, France
  April 12-15  
  ASAM - American Society of Addiction Medicine
San Diego, CA, USA
  View All Conventions  
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
Slide Library
Abstract Library
Live CME Meetings
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare
providers only. Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.